Latest report suggests that result of a strategic review will see the company’s product and IP arms separate, but current courtroom tussle with Comcast means the timing is not great
Blog
The Federal Circuit’s precedential judgment in Supernus Pharmaceuticals v Iancu is good news for rights holders – especially those in life sciences
Chaya Chandavasu, senior vice president for science and innovation at PTT Global Chemical, explains how IP strategy has helped the subsidiary of Thailand’s state-owned oil and gas giant better understand its technology space and attract joint…
After Microsoft’s headline grabbing decision to sign-up to the network last year, LOT CEO “absolutely expects IBM to join” once its Red Hat acquisition is finalised
Microsoft and Alphabet possess the strongest machine learning portfolios, but Chinese state-sponsored R&D and access to data has the potential to shift the power dynamics
The Asia IP Elite identifies companies and institutions in the region that have world class IP functions. Here we introduce the 18 latest additions and explain why they have made the cut
IP office director states that even TSMC, the island’s top patentee, relies on trade secrets to protect 90% of innovations
Your essential Sunday reading: a summary of all the stories posted on the IAM platform in the past week – as well as links to each one
Increased R&D outsourcing and patent licensing account for pharma’s diminishing representation among the world’s top 100 innovators, while technological diversification may also be playing its part
Ford faces new confrontation over alleged infringement of MIT-owned IP, but number of suits against car giant well down from 2012-2014 peak